Appen (APX) Capital Raise summary
Event summary combining transcript, slides, and related documents.
Capital Raise summary
19 Jan, 2026Capital Raising and Liquidity
Announced a fully underwritten institutional placement to raise A$50 million and a non-underwritten A$5 million share purchase plan at A$1.92 per share, targeting generative AI opportunities and balance sheet flexibility.
Placement represents approximately 11.6% of existing shares, with settlement on 16 October 2024 and trading from 17 October 2024.
Pro-forma cash balance post-placement estimated at US$62.4 million, enhancing liquidity for working capital and growth.
Eligible shareholders in Australia and New Zealand can apply for up to A$30,000 in new shares under the SPP, open from 18 October to 1 November 2024.
Barrenjoey Markets Pty Limited is acting as sole lead manager and underwriter for the placement.
Financial and Trading Update
Q3 FY24 revenue was US$54.12 million, down 12.9% year-on-year, but up 34.6% excluding Google.
Gross margin improved to 41.2% (from 33.6% in Q3 FY23), reflecting cost management and project mix.
Returned to underlying EBITDA profitability at US$1.01 million and underlying cash EBITDA of US$0.04 million in Q3 FY24.
Revenue trend is positive month-on-month in Q3 FY24 (excluding Google), supported by generative AI project growth.
China and Enterprise/Government divisions are experiencing significant revenue growth.
Project Pipeline and Working Capital Dynamics
Generative AI projects are high volume, short duration, and can cause spikes in revenue and working capital needs.
Crowd costs are incurred before customer receipts, increasing the need for liquidity during project bursts.
Project mix includes steady, ongoing work and short, sharp projects of varying sizes.
Preparedness for a range of project types is a priority.
Additional capital will support working capital needs, especially for generative AI projects requiring upfront crowd costs.
Latest events from Appen
- FY25 revenue and EBITDA surged, led by generative AI and China, with FY26 growth guidance set.APX
AGM 2026 - Q1 FY26 revenue up 9% year-over-year, led by Appen China's 88% growth and strong AI demand.APX
Q1 2026 TU - FY25 saw 4.5% revenue growth, 75% China surge, and margin gains; FY26 outlook is strong.APX
H2 2025 - Q4 FY25 revenue and EBITDA surged on generative AI and China growth, with strong cash gains.APX
Q4 2025 TU - China's 81% revenue growth drove Q3 gains, offsetting US volatility; FY25 guidance reaffirmed.APX
Q3 2025 TU - H1 revenue $102.1M, China up 67%, net loss $19.3M, FY25 guidance and positive EBITDA reaffirmed.APX
H1 2025 - Revenue down 18%, but cost cuts and generative AI drove improved profitability.APX
H1 2024 - Profitability restored, China and AI growth strong, with 2025 focused on tech and efficiency.APX
AGM 2025 - Profitability restored as generative AI and China drive growth, despite Google contract loss.APX
H2 2024